TruthArchive.ai - Related Video Feed

"This vaccine has six vaccines in one." "epinephrine and other appropriate agents and equipment must be available for immediate use if you're going to be giving this vaccination." "This vaccine is indicated for six weeks old through four years old." "a review by the Institute of Medicine found evidence for a causal, not correlation, causal relationship between tetanus toxoid, one of the components, and both brachial neuritis and Guillain Barre syndrome." "apnea, that's difficulty breathing, you kinda stop breathing, following intramuscular vaccination has been observed in some infants." "there is not a single randomized controlled study with an inert placebo. It's only tested against other vaccinations." "Three hundred nineteen micrograms of aluminum is used as an adjuvant." "Vaxelis has not been evaluated for carcinogenic or mutagenic potential or impairment of fertility."

The speaker discusses the Vaxelis vaccine, a six-in-one vaccine for children aged six weeks to four years, protecting against diphtheria, tetanus, pertussis, polio, Haemophilus B, and hepatitis B. The speaker references the package insert, noting epinephrine and other agents should be available during administration. The speaker highlights a review by the Institute of Medicine that found a causal relationship between tetanus toxoid and both brachial neuritis and Guillain Barre syndrome, a type of paralysis. Apnea following intramuscular vaccination has been observed in some infants. The speaker claims there were no randomized controlled studies with an inert placebo during the vaccine's development, only tests against other vaccinations. Ingredients include aluminum, formaldehyde, bovine serum albumin, neomycin, Streptomycin, and Polymyxin B. The speaker points out that Vaxelis has not been evaluated for carcinogenic or mutagenic potential or impairment of fertility.

“Day one of birth.” “they get one on day one of birth, they get another one a month later, they get another six months later.” It’s a “captive audience.” “How many babies are gonna be IV drug abusers or go out and have unprotected sex or get a blood transfusion from somebody who’s infected?” They claim “mom could have had hepatitis B” and that “mom was tested for hepatitis during her pregnancy,” so doctors would have known and could have “either treat it or do something about it or maybe prophylax the baby.” They ask, “Why would pediatricians go along with that? … money.” They warn, “If they’re giving infants treatment that the infant doesn’t need that has potentially harmful consequences and they’re doing it for money, then they’re criminals.” “there’s two hepatitis B vaccines that are in use.” They ask, “What the long term the follow-up study on those two hepatitis B vaccines is? No. Four days for one, five days for the other.” “Where’s the longitudinal study?” “They haven’t done it.” “That’s the vaccine industry.”

According to the speaker, most vaccines have never been tested in a randomized, placebo-controlled trial to evaluate their safety. The speaker claims that vaccines contain aluminum compounds because many dead vaccines don't mount an immune response without them. The speaker alleges that in a Gardasil vaccine study, the placebo group received an aluminum adjuvant instead of a true placebo, resulting in similar side effect profiles between the active vaccine and placebo groups. The speaker asserts that Merck used a novel aluminum compound and that data suggests aluminum in vaccines is profoundly toxic. The speaker states that the only true randomized controlled trial involving a vaccine was conducted on sheep with blue tongue disease. The results allegedly showed that the aluminum in the vaccine was toxic, causing the sheep to become sick, unsociable, and, in some cases, die. The speaker concludes that the assumption that aluminum adjuvants in vaccines are safe is unfounded and has never been tested.

Hepatitis B is contracted through sexual activity and IV drug use. The speaker believes babies do not need the hepatitis B vaccine. The hepatitis B vaccine contains 250 micrograms of aluminum. The speaker states that after Thimerosal was removed from vaccines, the hepatitis B vaccine was moved from being given to teenagers to newborns. The speaker claims the amount of aluminum in the vaccine is five times the adult daily maximum.

Checklist for summary approach: - Identify the core topics: trial design and safety monitoring, absence of control group, list of reported adverse events, causality vs association, need for placebo-controlled trials, regulatory and review positions (CDC, IOM), and final stance on vaccine safety. - Preserve key factual claims and phrases (e.g., monitoring duration, lack of control group, listed adverse events, causality requirements). - Emphasize any surprising or unique points (no pre-licensure placebo trial, IOM stance on data, final assertion about safety assumptions). - Exclude filler, repetition, and off-topic chatter; keep a neutral, fact-focused summary. - Translate only if needed; retain precise wording where quoted. - Keep the summary within 378-473 words. Summary: In the discussion about Recombivax HB, the speaker confirms the product and its labeling, noting that Section 6.1 covers pre-licensure clinical trial experience and that safety was monitored after each dose for five days. It is stated that five days is not long enough to detect autoimmune issues or neurological disorders arising after vaccination. The conversation also points out that there is no control group in those trials. Turning to Section 6.2, the nervous system disorders subsection acknowledges reports of Guillain-Barre syndrome and multiple sclerosis, including exacerbation, myelitis including transverse myelitis, seizures and febrile seizures, peripheral neuropathy including Bell’s palsy, muscle weakness, hypothesia, and encephalitis. It is emphasized that these reports are included because they have been reported to authorities as occurring after vaccination, not because they prove the vaccine caused those reactions. To establish causality, a randomized placebo-controlled study would be needed, but none was performed for this hepatitis B vaccine before licensure. Without a control group, evaluating whether a phenomenon in the vaccine group is related is not possible. A speaker comments that the broader issue is that such safety placebo trials were not done before licensure; once injuries are observed, they argue that it’s unethical to conduct placebo trials, and doctors may claim there are no studies showing the injuries are caused by the vaccine, leading to an assumption of safety. The discussion then touches on CDC guidance, with a question about agreeing with the recommendation that babies receive hepatitis B on the first day of life. The responder concedes that hepatitis B doesn’t cause encephalitis “in my opinion.” The IOM review is cited as having determined it “couldn’t find science to support a causal determination one way or another.” In the absence of data, the conclusion cited is that “there’s no proof that causation exists,” which is distinguished from saying it doesn’t cause it. The transcript closes with a provocative remark: “Vaccine safety is not based on science and data. And that is the stalemate we find ourselves in.”

None of the 72 vaccines for children have been tested against a placebo. The speaker sued HHS in 2016 to find placebo studies for vaccines, but none were found. The safety testing for the polio vaccine was only 48 hours, while the hepatitis b vaccines were tested for 4-5 days. This means that any adverse events occurring after that time period were not considered. Without placebo testing, the risk profile of current vaccines is unknown, and it cannot be determined if vaccines cause more harm than good. The speaker questions the ethics of mandating medical products with unknown risks for children.

The speaker discusses the Vaxelis vaccine, a six-in-one vaccine for children aged six weeks to four years, protecting against diphtheria, tetanus, pertussis, polio, Haemophilus B, and hepatitis B. The speaker notes the package insert states epinephrine and other agents must be available during vaccination. They highlight a review by the Institute of Medicine found a causal relationship between tetanus toxoid and both brachial neuritis and Guillain Barre syndrome, a type of paralysis. Apnea following intramuscular vaccination has been observed in some infants. The speaker claims there were no randomized controlled studies with an inert placebo, only tests against other vaccines. Ingredients include aluminum, formaldehyde, bovine serum albumin, neomycin, Streptomycin, and Polymyxin B. The speaker points out Vaxelis has not been evaluated for carcinogenic or mutagenic potential or impairment of fertility.

We couldn't find any prelicensing safety trials for the 72 vaccines doses that are recommended for American children. Unlike other medications, vaccines were exempt from conducting safety trials that compare health outcomes between a placebo group and a vaccine group. This lack of safety trials is concerning considering the widespread use of these vaccines.

In 1989, there was a sudden appearance of autoimmune diseases, allergic diseases, neurological diseases, and obesity. The CDC investigated a possible link to the vaccine schedule, specifically the hepatitis B vaccine. They compared children who received the vaccine within the first 30 days of life to those who received it later or not at all. The study showed a 1135% increased risk for subsequent autoimmune diagnosis in children who received the vaccine in the first 30 days. A relative risk of 2 presumes causation, and this study showed 11.35. An emergency meeting was held at Simpsonwood, a remote retreat center, with representatives from the vaccine and pharmaceutical industries, universities, NIH, CDC, FDA, WHO, and the European Medical Agency. According to a transcript of the meeting, the first day was spent discussing the legal implications of the findings, while the second day focused on how to conceal the information from the public.

Two hepatitis vaccines exist, and one of them had a safety study that lasted for four days on a 100 and forty three kids, a product that's gonna be given to the seventy six million kids. The risk profile prior to the introduction of the vaccine, the risk of a baby dying from hepatitis B was one in seven million. That means you need to give 7,000,000 hepatitis B vaccines to prevent one death if you're going to give seven. This statement emphasizes that the risk of infant death from hepatitis B was one in seven million. So, Mr. Sikh, and I guess before that.

The childhood vaccine schedule is managed by a vaccine advisory group with CDC and American Academy of Pediatrics representation. Changes would come to my desk for review, but this committee is very influential in vaccine policy. Regarding the hepatitis B vaccine, I'm surprised it's given to day-old babies based on limited safety data from a study with only a five-day review period and no placebo group. The FDA likely extrapolated adult data, but I don't think this establishes safety for newborns. I would prefer to see this vaccine given to older children. I disagree with the heavy-handed approach to vaccines, as it increases hesitancy and distrust. Doctors should educate, not badger or threaten, people about vaccines. I'm not a big advocate for one-year-olds getting the hepatitis B vaccine unless the mother is hepatitis B positive and the baby is at high risk.

The documentary follows a growing concern: the rise of chronic illness and neurodevelopmental disorders in American children, with speakers outlining striking statistics, personal stories, and contested science around vaccines. Key facts and patterns: - A shift from decades ago to today: more than forty percent of American children now have at least one chronic health condition; estimates cited include that over fifty-four percent of kids have a chronic disease, up from twelve point eight percent in the 1980s. One speaker emphasizes that in forty years there has been “the greatest decline in human health ever recorded.” - Autism rates have surged: just a few decades ago, one in ten thousand children had autism; today, one in thirty-one. Other listed conditions include ADD/ADHD, tics/Tourette’s, narcolepsy, sleep disorders, IBS, autoimmune diseases (rheumatoid arthritis, juvenile diabetes, lupus, Crohn’s), eczema, asthma, seizures, and various neurological issues. - The central question raised: what is causing this epidemic of chronic illness in kids? The film argues that rapid increases in incidence cannot be explained by genetic change alone, which would take generations. Story and study arc: - The narrative centers on a scientist who was willing to conduct a study into vaccine safety and vaccine injury, but who faced career-risking consequences when attempting to publish or disseminate results. - The film’s narrator and investigators say they compiled hidden-camera testimonies, interviews, and raw stories from parents whose children experienced serious adverse events after vaccines (eczema, seizures, chronic GI issues, sleep apnea, language loss, autonomic and neurological symptoms, and death in some cases). Stories include a child who lost language after vaccination, triplets who regressed into severe autism after their pneumococcal shot, and families describing chronic, ongoing medical crises following vaccines. - The film frames a broader debate: vaccines are safe and effective, with extensive global use and long-standing public health endorsement. Yet it argues that the vaccine safety narrative lacks certain types of trials, particularly double-blind placebo-controlled trials for childhood vaccines. It claims that, in some cases, no such trials exist prior to licensure, and that post-licensure safety surveillance is limited or incomplete. Vaccine safety testing and regulatory claims: - The film argues that none of the 72 vaccine doses on the childhood schedule has ever been subjected to a pre-licensure double-blind placebo-controlled trial, which is presented as the gold standard of safety testing. It asserts that safety assessments and post-licensure surveillance often rely on observational data rather than randomized trials. - A critical example is the hepatitis B vaccine (Recombivax HB): the FDA-approved trial cited shows safety monitoring for only five days after each dose, with no placebo control. The film argues this is insufficient to detect autoimmune or neurodevelopmental issues that could emerge years later. - Dr. Stanley Plotkin, a leading vaccine expert, is interviewed regarding whether five days of safety monitoring captures potential autoimmune or neurological adverse events; the dialogue suggests concern about the adequacy of such safety windows and controls. - The documentary presents the notion that the absence of a placebo-controlled vaccine safety trial is used to argue safety, while retrospective studies and unblinded cohort analyses hints at potential signals that would merit more rigorous testing. Henry Ford Health System and the “vaccinated vs unvaccinated” study: - Dell and others pursue a vaccinated-versus-unvaccinated study using Henry Ford Health System data, with the aim of comparing health outcomes in vaccinated and unvaccinated children. They argue that this kind of retrospective cohort study can reveal safety signals when randomized trials are unavailable. - The study reportedly found that vaccination exposure was associated with higher risks of several chronic conditions, including asthma, atopic diseases, autoimmune diseases (e.g., rheumatoid arthritis, SLE, Guillain-Barré syndrome), and neurodevelopmental disorders. They summarize that by ten years, 57% of vaccinated children had a chronic health condition versus 17% of unvaccinated children; overall, two to four times higher risks across several categories were reported, with notable differences in neurodevelopmental outcomes. - The study reportedly found zero chronic conditions in the unvaccinated group for several categories, though the vaccinated group showed higher incidence in many categories. Autism did not reach statistical significance in this study due to small numbers. The presenters emphasize that retrospective studies have limitations (confounding, follow-up length, healthcare-seeking behavior), but argue that the signal deserves publication and replication. - The Henry Ford study reportedly faced professional and institutional barriers: a threat of defamation, failed attempts to publish, and internal resistance. The documentary showcases a dinner meeting where Dr. Marcus Zervos expresses willingness to publish but ultimately faces career risk, leading to discussions about “Galileo moments” and whether data should be released despite pushback. Industry and public health responses: - The film juxtaposes the public health consensus—vaccines save lives, the schedule is well tested, and billions of people have been studied—with dissenting voices from physicians, scientists, and parents who argue that independent, large-scale vaccinated-versus-unvaccinated analyses are necessary to truly assess safety outcomes. - It includes testimonials from doctors who faced professional pushback after expressing concerns about broader vaccine safety questions or demonstrating adverse effects in patient populations. - The documentary frames a call to replicate the retrospective study in other large health systems (e.g., Kaiser Permanente, Harvard Pilgrim, CDC’s VSD) to determine whether the Henry Ford findings hold across populations, and whether impaired health outcomes correlate with the breadth of vaccination exposure. Conclusion and call to action: - The film asserts that if the data are valid, this would constitute a sea-change in our understanding of off-target and nonspecific effects of vaccination and would necessitate reconsidering how the vaccination program is designed and implemented. - Viewers are urged to consider the evidence, demand replication, and reflect on the moral and ethical implications of vaccine safety research, balancing public health benefits with potential risks, and exploring alternate strategies to protect child health.

We couldn't find a prelicensing safety trial for any of the 72 vaccines doses recommended for American children. Unlike other medications, vaccines were exempt from conducting safety trials that compare health outcomes between a placebo group and a vaccine group.

In 1989, there was a notable increase in autoimmune diseases, including juvenile diabetes, rheumatoid arthritis, and lupus, which were rarely seen before. The CDC investigated a potential link to the hepatitis B vaccine, finding a staggering 1135% increased risk for those vaccinated within the first 30 days. This relative risk was higher than that of smoking and lung cancer. Following this discovery, an emergency meeting was held away from the CDC to discuss the findings. Attendees included representatives from the vaccine industry, pharmaceutical companies, and health organizations. The first day focused on the undeniable evidence, while the second day was dedicated to strategies for concealing the information from the public.

In 2007 trial, the placebo contained a toxic agent, affecting the comparison between vaccine and control groups. Both groups had 3% new autoimmune conditions, but it was dismissed. The lack of questioning raises concerns about vaccine safety. Comparing the 3% to general population rates would be logical. Individuals like Julie Gerberding and Peter Marks, who have ties to big pharma, may overlook such issues. Gerberding's move from CDC director to Merck's vaccines president with a $4,000,000 bonus raises ethical questions.

"Post marketing observational studies, increased risk of GBS, Guillain Barre syndrome, was observed during the forty two days following the Shingrix vaccine." "This is not correlation. This is causation." "This is grown in Chinese hamster ovary cells, and they tell us that there is residual amount of host cell proteins in the vaccine itself." "It also contains polysorbate eighty in addition to an adjunct an adjuvant that's called a s zero one b." "The problem with this product is that it can overstimulate the immune system. It can cause severe local and systemic reactions." "Shingrix has not been evaluated for its carcinogenic or mutagenic potential. Translation, we don't know if this product could lead to cancer." "If you're older than 80, you would have to treat three hundred and fifty six patients with the Shingrix vaccine to prevent one case of postherpetic neuralgia."

Vaccines are neither safe, effective, necessary, nor harmless, and this has been a two-hundred-year indoctrination. No vaccine has ever been proven safe because true placebos aren't used, and subjects aren't followed long enough. Safety is determined by whether the vaccine causes immediate death. Long-term effects like asthma, allergies, eczema, ADD, ADHD, neurological problems, and autoimmune diseases are not monitored. The FDA arbitrarily decided in the early 1990s that side effects appearing more than 72 hours after vaccination are unrelated.

"There is not one longitudinal safety study on hepatitis b against unvaccinated kids versus vaccinated kids, inert placebo, does not exist." "The two studies that are cited most often, one is for MMR." "Hep B is not involved." "They're like, we did a huge study about this. No autism." "And I'm not suggesting there's a link. I'm simply saying that huge study is only MMR." "The other study they love to talk about involves thimerosal." "Not everything else about the hepatitis B vaccine." "There the there the reality is it's not settled science. Just it's okay." "Vaccines have like, we could but to even say that, anti vaxxer."

The speakers discuss adverse reactions listed in Section 6.2 of a vaccine's package circular. They mention hypersensitive reactions, autoimmune diseases, nervous system disorders, and other conditions. The first speaker emphasizes that the presence of these reactions in the circular does not prove causation. The second speaker brings up the 2011 IOM report, which did not establish a causal relationship between the vaccine and multiple sclerosis. They discuss the need for a randomized, placebo-controlled study to determine causation. The second speaker questions the length of the safety review period for another hepatitis B vaccine and requests proof of any post-administration reactions. The presence of a control group in the trial is also discussed.

The transcript follows a documentary-style examination of rising chronic illness in American children and a contested view of vaccine safety and testing. It weaves together personal testimonies, investigative reporting, and expert interviews to present a narrative that vaccines may be linked to widespread health problems and that the safety science behind vaccination is insufficient or flawed in certain respects. Key claims about child health trends - A diverse set of pediatric health issues is described as increasingly common: ADHD, allergies, eczema, psoriasis, autoimmune diseases (rheumatoid arthritis, juvenile diabetes, lupus, Crohn’s disease), IBS, sleep disorders, seizures, and neurological conditions. Several speakers list multiple conditions affecting children, suggesting a broad chronic disease trend. - A striking statistic cited: “More than forty percent of American children now have at least one chronic health condition” (Speaker 5). Relatedly, autism rates are described as rising from “one in ten thousand” decades ago to “one in thirty one” today (Speaker 5). - An overarching contention is that these rapid increases are unlikely to be explained by genetics alone, given the relatively fast pace of change in incidence. The central study and the “hidden” narrative - The documentary frames a study led by a scientist who allegedly conducted research into chronic disease and vaccination but chose not to publish due to fear of repercussions. Hidden-camera investigations and interviews are used to explore why such data might remain unpublished and how the medical establishment responds to dissenting findings. - The film positions Dr. Zervos (Marcus Zervos), an infectious disease expert at Henry Ford Health System, as a pivotal figure who agreed to a vaccinated-versus-unvaccinated study but reportedly did not publish the results, leading the filmmakers to pursue further inquiry with him and others. Vaccines, safety testing, and the placebo question - A core claim is that vaccines have not undergone the gold standard of safety testing: double-blind, randomized, placebo-controlled trials for the entire childhood schedule. The film argues that no childhood vaccine has completed such a trial prior to licensure. - The hepatitis B vaccine (Recombivax HB) is used as an example: its pre-licensure safety data reportedly cover only five days after each dose, with no long-term control group, and section 6.1 of the insert notes five days of safety monitoring, raising questions about detecting longer-term autoimmune or neurological injuries. - Opposing voices acknowledge ethical constraints around placebo trials in the presence of existing vaccines, but the documentary challenges this by pointing out that certain comparator trials (e.g., Prevnar 13 vs Prevnar 7) were not against saline placebo, and thus do not establish a safety baseline. - A recurring metaphor is the “whiskey study” scenario to illustrate how non-saline placebo comparisons can mislead safety conclusions. Retrospective and observational studies; the vaccine-safety signal - The film emphasizes retrospective and observational studies as alternatives to randomized trials, arguing they can reveal safety signals when prospective trials are unavailable. It highlights the Henry Ford Health System’s data as a major retrospective study: a vaccinated-versus-unvaccinated analysis based on a large, integrated health database. - According to the film, the Henry Ford study found that vaccinated children had higher risks across multiple chronic health categories. Specifically, ten years of follow-up suggested: - Vaccinated children were 2.5 times more likely to have a chronic health condition overall. - An approximate fourfold increased risk for chronic health conditions in certain analyses. - A 4.29-times higher risk for autism was not statistically significant due to small autism counts in the unvaccinated group, but substantial signals were observed in other neurodevelopmental outcomes. - The study reported markedly higher rates of autoimmune diseases (around six times higher) and various neurodevelopmental disorders in the vaccinated group compared with unvaccinated peers. - In the ten-year window, 57% of vaccinated children had a chronic health condition versus 17% of unvaccinated children. - The documentary notes methodological limitations common to retrospective studies, such as follow-up differences and confounding factors, but argues that sensitivity analyses did not overturn the main findings. The vaccine schedule, broader policy, and dissent within the medical community - The narrative asserts that a large portion of physicians publicly defend vaccines as safe and effective, with long-standing support for vaccination policies and mandates. Yet it also recounts stories of physicians who faced professional pushback, licensing actions, or public criticism after raising questions about vaccine safety or suggesting alternative research paths. - The film mentions the Institute of Medicine’s 2011 report, which stated that there were over 150 injuries likely associated with vaccines that had not been studied, and it notes that no large, randomized comparisons between fully vaccinated and fully unvaccinated populations had been published by major institutions (as of the report’s release). - The filmmakers recount efforts to obtain a definitive vaccination–unvaccinated study from Henry Ford and other institutions, with some figures expressing willingness to publish if the study clearly demonstrated that unvaccinated children fared better, while others face professional or political pressures. Vaccine advocacy versus safety concerns; the call for replication - Pro-vaccine voices in the film emphasize that vaccines have prevented millions of deaths and remain broadly safe, citing the historical success of vaccines and the large body of published research supporting vaccine effectiveness and safety. - Proponents of re-examination advocate replicating retrospective cohort analyses in other large health systems (e.g., Kaiser Permanente, Harvard Pilgrim, CDC’s VSD) to test whether similar patterns emerge. They stress the ethical and scientific necessity of replication to determine whether the observed signals hold across populations. - The film closes with a call for replication and transparency: if the data are robust, publishing them could transform the understanding of off-target and non-specific effects of vaccination. If replicated, such studies could reshape how vaccines are administered and studied. The documentary also threads personal stories of vaccine injury, including cases of severe reactions after various vaccines and the emotional and logistical toll on families. It juxtaposes these individual tragedies with the broader debate over vaccine safety research, urging readers to consider the evidence, replication, and the possibility that current vaccine safety paradigms may require reassessment.

According to the speaker, vaccines have never been tested in a randomized, placebo-controlled trial to evaluate their safety. The speaker claims that vaccines contain aluminum compounds because many dead vaccines don't mount an immune response without them. The speaker alleges that in a Gardasil vaccine study, the placebo group received an aluminum adjuvant instead of a true placebo, so the side effect profiles of the active vaccine and placebo groups were the same. The speaker asserts that Merck used a novel aluminum compound and that data shows aluminum in vaccines is toxic. The speaker states that the only completely randomized controlled trial was on sheep using a vaccine for blue tongue disease. The speaker claims the aluminum was toxic, the sheep became sick, their behavior changed, and many died compared to the placebo group. The speaker concludes that the presumption that aluminum as an adjuvant is safe is unfounded and has never been tested.

In 1989, there was a sudden rise in autoimmune diseases like juvenile diabetes, rheumatoid arthritis, lupus, and obesity. The CDC investigated the hepatitis B vaccine's role in this increase. They found that children vaccinated within the first 30 days had an 1135% increased risk of autoimmune diagnoses compared to those vaccinated later or not at all. Recognizing the significance of this finding, the CDC held an emergency meeting at a remote retreat to discuss the study. The first day focused on the undeniable evidence and potential legal repercussions, while the second day was dedicated to strategies for concealing the information from the public. Excerpts from the meeting were later published, highlighting the tension between acknowledging the findings and the desire to suppress them.

Fluzone package insert: Indicated for six months of age and older. Adverse reactions for kids, normal crying, malaise, drowsiness, appetite loss, vomiting, fever, and headache. Section 5.1 under warnings and precautions. evidence for a causal relationship, not correlation, but causation of Guillain Barre syndrome. Guillain Barre is described as a type of partial paralysis that looks a lot like polio with influenza vaccine. The decision to give Fluzone quadrivalent should be based on careful consideration of potential benefits and risk. Fluzone has not been evaluated for carcinogenic or mutagenic potential or for impairment of fertility. There are no placebo controlled randomized trials for this product. They base efficacy simply on the ability of the product to elicit antibody response that's measured in the blood. Translation. We don't know if this product causes cancer or can interfere with reproductive health, but let's give it to a six month old. Informed consent.

We documented six sixty 1 trials using inert placebo controls and confirmed that all 16 antigens routinely recommended for children have been studied in placebo controlled trials. The claim that childhood vaccines haven't been tested against placebos is demonstrably false. Drilling into the 661 trials, 567 were not a routine injected vaccine for disease on the CDC's childhood schedule; the remaining 94 studies, 70 did not involve healthy children; of the remaining 24, 21 did not involve a US licensed vaccine. That leaves three studies claimed to have an inert control used to license a routine injected childhood vaccine. One varicella trial had only a few hundred participants and, though called inert, used neomycin instead. The Gardasil 4 trial's control group largely received an aluminum adjuvant injection; a few hundred labeled inert were not inert. The Gardasil 9 trial used a saline injection only after three doses of Gardasil 4. The result: zero trials used a placebo as well as a true inert control to license a routine injected vaccine on the CDC schedule.